Atlas Trials

Palbociclib Induced Neutropenia; Risk Factors and Treatment Outcome in Metastatic Breast Cancer Patients

Clinical trial NCT06076772 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06076772
Sponsor
Assiut University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Metastatic Breast Cancer
Start date
2023-11-01
Primary completion
2026-09-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.